Medicamen Biotech Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 26, 2024
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech Limited held its 32nd Annual General Meeting on September 26, 2025, starting at 12:00 PM and concluding at 12:55 PM, conducted through video conferencing. Chairman Mr. Rahul Bishnoi chaired the meeting, with Company Secretary Ms. Parul Choudhary facilitating the proceedings. Nine resolutions were put to vote, including adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, declaration of a final dividend on equity shares, reappointment of Mr. Rahul Bishnoi and Dr. Vimal Kumar Shrawat as directors retiring by rotation, ratification of cost auditors' remuneration, appointment of Mr. Ashwani Kumar Sharma as Whole-time/Executive Director for five years, appointment of Mr. Sham Goel and Mr. Shaival Saurabh as Non-Executive Independent Directors, and appointment of M/s AMJ & Associates as Secretarial Auditor. Remote e-voting was held from September 23-25, 2025, with M/s AMJ & Associates acting as scrutinizer. Quorum was confirmed present, and shareholder queries were addressed during the meeting.
This is a standard procedural disclosure confirming the AGM was conducted with all required items put to vote; the actual financial impact, including the final dividend amount and outcomes of each resolution, awaits the scrutinizer's report and e-voting results which the company will communicate separately. No major surprises or extraordinary corporate actions were announced.